Safecare COVID-19 & Influenza A+B Antigen Combo Rapid Self-Test
Safecare COVID-19 & Influenza A+B Antigen Combo Rapid Self-Test
The Safecare COVID-19 & Influenza A+B Antigen Combo Rapid Self-Test offers a versatile, cost-effective solution for at-home testing of COVID-19 and Influenza A/B. This combo test makes it easy for individuals to test themselves, providing peace of mind and promoting public health.
The Safecare COVID-19 & Influenza A+B Antigen Combo Rapid Self-Test is an essential tool for efficient, reliable detection of respiratory infections. Suitable for both symptomatic and asymptomatic individuals, this combo test kit supports public health efforts by enabling early detection and timely isolation when necessary.
Product Specifications
- Detection Capability: Identifies the presence of COVID-19, Influenza A, and Influenza B.
- Sensitivity and Specificity:
- SARS-CoV-2: Sensitivity 97.04% / Specificity 99.44%
- Influenza A: Sensitivity 100% / Specificity 99.44%
- Influenza B: Sensitivity 100% / Specificity 100%
- Intended Use: Designed for home use, enabling individuals to self-test for symptomatic and asymptomatic infections.
- Detection: Capable of detecting all COVID-variants.
- Result Time: Fast results in just 15 minutes.
- Usability: Easy to perform with fast and reliable outcomes.
- Sampling Method: Nasal Swab
- Packaging: Each package contains 1 test kit.
Benefits
- High Sensitivity and Specificity: Ensures accurate results, reducing the likelihood of false positives or negatives.
- Quick and Reliable Results: Obtain results rapidly to help make informed decisions.
- Home Convenience: Conduct tests effortlessly at home without the need for professional oversight.
- Comprehensive Coverage: Detects a range of viral infections including various COVID-19 variants and Influenza A/B.
- Regulatory Compliance: Meets stringent EU health and safety regulations, offering reassurance to users.
Technical Data
- Test Type: Rapid antigen test for the qualitative determination of SARS-CoV-2, Influenza A, and B antigens.
- Sample Collection: Utilizes anterior nasal swabs for easy, non-invasive sampling.
- Compliance and Certification:
- CE 2934 Certified
- Adheres to EN ISO 13485:2016
- Performance: Reliable performance for detecting all COVID-19 variants.
- Sensitivity and Specificity:
- SARS-CoV-2: Sensitivity 97.04% / Specificity 99.44%
- Influenza A: Sensitivity 100% / Specificity 99.44%
- Influenza B: Sensitivity 100% / Specificity 100%
FAQ's About Safecare COVID-19 & Influenza A+B Antigen Combo Rapid Test Product
What is the Safecare COVID-19 & Influenza A+B Antigen Combo Rapid Test?
The Safecare COVID-19 & Influenza A+B Antigen Combo Rapid Test is a diagnostic tool designed to detect the presence of both COVID-19 and Influenza A+B antigens. It falls under the product category of combo antigen test kits, allowing for the determination of SARS-CoV-2 virus antigen and influenza antigens using nasal swab specimens.
How does the test detect COVID-19 and Influenza A+B?
The test detects the nucleocapsid protein antigen from nasal swab specimens. It is clinically validated to identify the presence of SARS-CoV-2 virus antigen in anterior nasal swabs, as well as influenza antigens, providing a comprehensive assessment for these respiratory infections.
Who is the test intended for?
This test is intended for symptomatic individuals who suspect they may have COVID-19 or influenza. It is designed for home use, allowing individuals to perform the test themselves and obtain results quickly.
What should individuals do if they test positive?
Individuals who test positive for either COVID-19 or influenza should self-isolate to prevent the spread of the virus. It is also recommended to contact a healthcare provider for further guidance and to find complete details about COVID-19 management.
How soon after exposure can the test detect COVID-19?
The test is most effective when used within the first seven days of symptom onset. COVID-19 is an acute respiratory illness, and early detection is crucial for effective management and isolation.
Are there any related products available?
Yes, there are related products available that also fall under the product category of antigen test kits. These products may focus on detecting either COVID-19 or influenza antigens separately or offer alternative testing methods.
How accurate is the antigen test?
The antigen test is clinically validated, ensuring a high level of accuracy in detecting the presence of SARS-CoV-2 virus antigen and influenza antigens in anterior nasal swabs. However, no test is 100% accurate, and results should be confirmed with a healthcare provider.
Can the test be used for asymptomatic individuals?
While the test is primarily intended for symptomatic individuals, it can be used by asymptomatic individuals who suspect exposure to COVID-19 or flu. It is important to follow up with a healthcare provider for further evaluation if needed.
Can the test be used for children under 14 years?
The test is intended for home use, but children under 14 years should be assisted by an adult to ensure accurate sample collection and result interpretation.
What should I do if I test positive for COVID-19 or influenza?
If you test positive, you should self-isolate and seek additional guidance and assistance from healthcare professionals to prevent the spread of infectious disease.
Is the test clinically validated?
Yes, the test has been clinically validated in the EU, providing clinical validation you can trust for the rapid qualitative determination of SARS-CoV-2 and influenza viruses.
Can this test be used as the sole basis for diagnosing COVID-19 or influenza?
No, the test should not be used as the sole basis for diagnosing COVID-19 or influenza. Positive results should be confirmed with additional testing and consultation with healthcare professionals.
Login